Method Protocols for Metabolic and Functional Analysis of the BRIN-BD11 β-Cell Line: A Preclinical Model for Type 2 Diabetes

Methods Mol Biol. 2019:1916:329-340. doi: 10.1007/978-1-4939-8994-2_32.

Abstract

In type 2 diabetes, prolonged dysregulation of signalling and β-cell metabolic control leads to β-cell dysfunction, and is increasingly associated with abnormal metabolic states which disrupt normal cellular physiology. Utilization of appropriate β-cell models enables a systematic approach to understand the impact of perturbations to the biological system. The BRIN-BD11 β-cell line is a useful, pre-clinical cell model for β-cell dysfunction associated with type 2 diabetes, among other metabolic disorders. The present chapter describes detection and analysis of β-cell dysfunction with respect to changes in bioenergetics and metabolism, generation of intracellular reactive oxygen species, and acute and chronic insulin secretion in the BRIN-BD11 cell line.

Keywords: BRIN-BD11 β-cells; Bioenergetics; Diabetes; Insulin; Metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Culture Techniques / methods*
  • Cell Line / metabolism
  • Cell Line / pathology
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / pathology
  • Glucose / metabolism
  • Humans
  • In Vitro Techniques / methods*
  • Insulin / metabolism
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / pathology*
  • Reactive Oxygen Species

Substances

  • Insulin
  • Reactive Oxygen Species
  • Glucose